Utilization of oncology services and receipt of treatment: A comparison between patients with breast, colon, rectal, or lung cancer

Annals of Oncology

Volumn 22, Issue 8, 2011, Pages 1902-1909

  Li, X ^a   Butts, C ^a,b   Fenton, D ^a,b   King, K ^a,b   Scarfe, A ^a,b   Winget, M ^a,b  

^a ALBERTA HEALTH SERVICES   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Access to cancer care; Health services research; Oncology consultation; Treatment disparities

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGE; AGED; ARTICLE; BREAST CANCER; BREAST SURGERY; CANADA; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER STAGING; COLON CANCER; COLON SURGERY; CONSULTATION; CONTROLLED STUDY; DEMOGRAPHY; ELECTRONIC MEDICAL RECORD; HEALTH CARE DELIVERY; HEALTH CARE DISPARITY; HEALTH CARE UTILIZATION; HORMONAL THERAPY; HUMAN; LUNG CANCER; LUNG SURGERY; MAJOR CLINICAL STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; RECTUM CANCER; RECTUM SURGERY; TREATMENT OUTCOME;

EID: 79960982091     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdq692     Document Type: Article

References (67)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global Cancer Statistics, 2002. CA Cancer J Clin 2005; 55(2): 74.
2. Cancer in North America: 2002-2006. Volume One: Combined Cancer Incidence for the United States and Canada. Springfield, IL: North American Association of Central Cancer Registries Inc. 2009.
3. Edwards BK, Ward E, Kohler BA et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 2010; 116(3): 544-573.
4. Chronic Disease Surveillance Division. Cancer Surveillance On-Line-Males, All Ages, 2005, Canada-Age-Standardized Mortality Rate per 100,000 (Canada 1991). Public Health Agency of Canada 2010; http://dsol-smed.hc-sc.gc.ca/dsol-smed/cancer/cgi-bin/cancerchart2?DATA_TYPE=R&CAUSE=064&CAUSE=036&CAUSE=732&YEAR=05&AREA=00&AGE=0&SEX=1&DATA_SET=MORT&CCAUSE1=View+Chart (26 May 2010, date last accessed).
5. National Cancer Institute. Cancer Health Disparities. National Cancer Institute Fact Sheet. http://www.cancer.gov/cancertopics/factsheet/cancer-health-disparities/disparities#5 (26 May 2010, date last accessed).
6. Jemal A, Ward E, Thun M. Declining death rates reflect progress against cancer. PLoS One 2010; 5(3): e9584.
7. Edwards BK, Brown ML, Wingo PA et al. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst 2005; 97(19): 1407-1427.
8. Jemal A, Clegg LX, Ward E et al. Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer 2004; 101(1): 3-27.
9. Weir HK, Thun MJ, Hankey BF et al. Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst 2003; 95(17): 1276-1299.
10. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Colon Cancer V.3. Jenkintown, PA: NCCN 2005.
11. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Rectal Cancer. V.3. Jenkintown, PA: NCCN 2005.
12. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Non-Small Cell Lung Cancer. V.2. Jenkintown, PA: NCCN 2005.
13. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Breast Cancer. V.2. Jenkintown, PA: NCCN 2005.
14. Perez E, Muss HB. Optimizing adjuvant chemotherapy in early-stage breast cancer. Oncology (Williston Park) 2005; 19(14): 1759-1767.
15. Kuru B, Camlibel M, Dinc S et al. A comparison of the outcomes of non-randomised chemotherapy regimens in node positive breast cancer. J Exp Clin Cancer Res 2005; 24(3): 363-372.
16. Meyerhardt JA, Mayer RJ. Systemic therapy for colorectal cancer. N Engl J Med 2005; 352(5): 476-487.
17. Arkenau HT, Bermann A, Rettig K et al. 5-Fluorouracil plus leucovorin is an effective adjuvant chemotherapy in curatively resected stage III colon cancer: long-term follow-up results of the adjCCA-01 trial. Ann Oncol 2003; 14(3): 395-399.
18. Arriagada R, Bergman B, Dunant A et al. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 2004; 350(4): 351-360.
19. Grothey A, Sargent D, Goldberg RM, Schmoll HJ. Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment. J Clin Oncol 2004; 22(7): 1209-1214.
20. Erridge SC, Gaze MN, Price A et al. Symptom control and quality of life in people with lung cancer: a randomised trial of two palliative radiotherapy fractionation schedules. Clin Oncol (R Coll Radiol) 2005; 17(1): 61-67.
21. Mystakidou K, Katsouda E, Kouloulias V et al. Comparison of transdermal fentanyl with codeine/paracetamol, in combination with radiotherapy, for the management of metastatic bone pain. J Opioid Manag 2005; 1(4): 204-210.
22. Suhag V. Palliative therapy in cancer patients: an overview. JK Sci 2005; 7(2): 61-66.
23. Lewis-Wambi JS, Jordan VC. Treatment of postmenopausal breast cancer with selective estrogen receptor modulators (SERMs). Breast Dis 2005; 24: 93-105.
24. Dimitrakakis C, Keramopoulos D, Vourli G et al. Clinical effects of tibolone in postmenopausal women after 5 years of tamoxifen therapy for breast cancer. Climacteric 2005; 8(4): 342-351.
25. Fritz A, Percy C, Jack A et al. (eds). International Classification of Diseases for Oncology, 3rd edition. Geneva, Switzerland: World Health Organization 2000.
26. Greene FL, Page DL, Fleming ID et al. AJCC Cancer Staging Manual, 6th edition. New York: Springer 2002.
27. Rosner B. Fundamentals of Biostatistics, 6th edition. Belmont, CA: Thomson-Brooks/Cole 2006.
28. Agresti A. Categorical Data Analysis. New York: Wiley-Interscience 2002.
29. Harrell FE. Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis. New York: Springer 2001.
30. Deddens JA, Peterson MR. Approaches for estimating prevalence ratios. Occup Environ Med 2008; 65: 501-506.
31. Keating NL, Landrum MB, Ayanian JZ et al. Consultation with a medical oncologist before surgery and type of surgery among elderly women with early-stage breast cancer. J Clin Oncol 2003; 21(24): 4532-4539.
32. Luo R, Giordano SH, Freeman JL et al. Referral to medical oncology: a crucial step in the treatment of older patients with stage III colon cancer. Oncologist 2006; 11: 1025-1033.
33. Morris AM, Billingsley KG, Hayanga AJ et al. Residual treatment disparities after oncology referral for rectal cancer. J Natl Cancer Inst 2008; 100(10): 738-744.
34. Earle CC, Neumann PJ, Gelber RD et al. Impact of referral patterns on the use of chemotherapy for lung cancer. J Clin Oncol 2002; 20(7): 1786-1792.
35. Harlan LC, Abrams J, Warren JL et al. Adjuvant therapy for breast cancer: practice patterns of community physicians. J Clin Oncol 2002; 20(7): 1809-1817.
36. Potosky AL, Harlan LC, Kaplan RS et al. Age, sex, and racial differences in the use of standard adjuvant therapy for colorectal cancer. J Clin Oncol 2002; 20: 1192-1202.
37. Potosky AL, Saxman S, Wallace RB, Lynch CF. Population variations in the initial treatment of non-small-cell lung cancer. J Clin Oncol 2004; 22(16): 3261-3268.
38. Townsley C, Pond GR, Peloza B et al. Analysis of treatment practices for elderly cancer patients in Ontario, Canada. J Clin Oncol 2005; 23(16): 3802-3810.
39. Johnson A. Insurer plays judge on cancer care: United Healthcare sends doctors individualized reports. The Wall Street Journal 2010 [a complaint on E-mail].
40. Harlan LC, Greene AL, Clegg LX et al. Insurance status and the use of guideline therapy in the treatment of selected cancers. J Clin Oncol 2005; 23(36): 9079-9088.
41. Arrieta O, Michel Ortega RM, Villanueva-Rodriguez G et al. Association of nutritional status and serum albumin levels with development of toxicity in patients with advanced non-small cell lung cancer treated with paclitaxel-cisplatin chemotherapy: a prospective study. BMC Cancer 2010; 10: 50.
42. Forrest LM, McMillan DC, McArdle CS et al. Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer. Br J Cancer 2004; 90(9): 1704-1706.
43. McCloskey SA, Tao ML, Rose CM et al. National survey of perspectives of palliative radiation therapy: role, barriers, and needs. Cancer J 2007; 13(2): 130-137.
44. Samant RS, Fitzgibbon E, Meng J, Graham ID. Barriers to palliative radiotherapy referral: a Canadian perspective. Acta Oncol 2007; 46(5): 659-663.
45. Yancik R, Ershler W, Satariano W et al. Report of the national institute on aging task force on comorbidity. J Gerontol A Biol Sci Med Sci 2007; 62(3): 275-280.
46. Pal SK, Hurria A. Impact of age, sex, and comorbidity on cancer therapy and disease progression. J Clin Oncol 2010; 28(26): 4086-4093.
47. Winget M, Hossain S, Yasui Y, Scarfe A. Characteristics of patients with stage III colon adenocarcinoma who fail to receive guideline-recommended treatment. Cancer 2010; 116(20): 4849-4856.
48. Ayanian JZ, Zaslavsky AM, Fuchs CS et al. Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort. J Clin Oncol 2003; 21: 1293-1300.
49. Bolton WD, Rice DC, Correa AM et al. Influence of age on choice of therapy and surgical outcomes in patients with nonsmall cell lung cancer. Am Surg 2009; 75(7): 598-603.
50. Blanco JA, Toste IS, Alvarez RF et al. Age, comorbidity, treatment decision and prognosis in lung cancer. Age Ageing 2008; 37(6): 715-718.
51. Barthelemy P, Heitz D, Mathelin C et al. Adjuvant chemotherapy in elderly patients with early breast cancer. Impact of age and comprehensive geriatric assessment on tumor board proposals. Crit Rev Oncol Hematol 2010; in press.
52. Houterman S, Janssen-Heijnen ML, Verheij CD et al. Comorbidity has negligible impact on treatment and complications but influences survival in breast cancer patients. Br J Cancer 2004; 90(12): 2332-2337.
53. About NBCC. National Breast Cancer Coalition 2008 http://www.stopbreastcancer.org/index.php?option=com_content&task=view&id=134&Itemid=62 (26 May 2010, date last accessed).
54. 2009 Golf Fore the Cure Raises over $800,000 in Support of Breast Cancer Research. Royal Canadian Golf Association 2009; http://www.rcga.org/news_details.aspx?id=2109 (26 May 2010, date last accessed).
55. Community Caring. Safeway Inc. 2009; http://www.safeway.com/ifl/grocery/community-caring.
56. Where Money Comes From. Canadian Breast Cancer Foundation 2010; http://www.cbcf.org/en-US/CBCF%20in%20Action/YIP/Where%20the%20money%20comes%20from.aspx (26 June 2010, date last accessed).
57. Learn More about NBCF-Events. National Breast Cancer Foundation Inc. 2010; http://www.nationalbreastcancer.org/About-NBCF/Events.aspx (26 May 2010, date last accessed).
58. Susan G. Komen Race for the Cure-Find a Local Race for the Cure. Susan G. Komen Race for the Cure 2010; http://ww5.komen.org/findarace.aspx (26 May 2010, date last accessed).
59. Fundraising Events Breastcancer.org. Breastcancer.org 2010; http://www.breastcancer.org/about_us/supporters/fundraising/ (26 May 2010, date last accessed).
60. Fundraising Events. Colorectal Cancer Association of Canada 2010; http://www.colorectal-cancer.ca/en/events-and-raising/ccac-fund-events/ (26 May 2010, date last accessed).
61. The Annual Walk/Run for Colon Cancer Canada. Colon Cancer Canada 2010; http://www.coloncancercanada.ca/annual_walkrun_event_2010.php (26 May 2010, date last accessed).
62. Mission Statement for the Colon Cancer Challenge Foundation. Colon Cancer Challenge Foundation Inc. 2010; http://www.coloncancerchallenge.org/mission.html (26 May 2010, date last accessed).
63. About Colon Cancer. Prevent Cancer Foundation 2010; http://www.preventcancer.org/colorectal3c.aspx?id=1048USA (26 May 2010, date last accessed).
64. Lung Cancer Voice. National Lung Cancer Partnership 2009; http://www.nationallungcancerpartnership.com/newsletter/Summer2009.pdf.
65. 5th Annual Leon Benoliel Golf Tournament. Lung Cancer Canada 2010; http://www.lungcancercanada.ca/Awareness/Events/Golf_Tournament.html (26 May 2010, date last accessed).
66. November Is Lung Cancer Awareness Month! Lung Cancer Alliance 2010; http://www.lungcanceralliance.org/involved/lcam_month.html (26 May 2010, date last accessed).
67. Scheduled Events. Lung Cancer Foundation of America 2010; http://www.lcfamerica.org/scheduled_events.html (26 May 2010, date last accessed).